Helicobacter pylori is considered the etiological agent of peptic ulcers and gastritis and is associated with mucosa-associated lymphoid tissue lymphoma and gastric cancer (4) . Although treatment is usually effective, it can result in side effects, such as antibiotic resistance development (14) and relapse due to low compliance (2) . Therefore, alternative methods should be explored to treat H. pylori infection.
Studies have reported many natural plant extracts with anti-H. pylori activity, including garlic, broccoli, cranberries, and green tea (5, 12, 16, 26) . Grapes (Vitis vinifera), well known for their high levels of antioxidants and polyphenols, have also shown promise as novel antimicrobial agents. A few studies have already reported the anti-H. pylori activities of grape seed and wine, including an active chemical constituent (e.g., resveratrol, a stilbene from red wine) (13) . However, no effort has been made to evaluate the grape skin or different grape types (e.g., table and muscadine grapes). For example, muscadines (Vitis rotundifolia) contain significantly higher levels of phenolics than commercial table grapes in addition to possessing some unique forms of these compounds (23) . However, little is currently known about the antibacterial properties these fruits possess, making them prime candidates for study. In addition, it is believed that the high complexity of bioactive compounds present in these products and their broad range of activity over a number of microorganisms may make it difficult for microbes to acquire resistance during treatment (26) .
The objectives of this study were to investigate the effects of various grape extracts against H. pylori and to determine any correlations between anti-H. pylori activity and extract phenolic content.
Five (8) . Liquid cultures were grown in brucella broth (Difco) (pH 7.0 Ϯ 0.2) supplemented with 10% HS and incubated, with shaking (60 rpm), under the same conditions. Cultures were transferred from frozen stock (brucella broth-HS-10% glycerol, Ϫ80°C), subcultured twice, and then grown overnight for antimicrobial susceptibility testing.
Fresh grapes were purchased from a local supermarket. Skins from red, white, and black table grapes were dried at 70°C for 3 days in a gravity convection oven (Fisher Scientific, Gaithersburg, MD). Muscadine powder was provided by Muscadine Products Corporation (Wray, GA). Samples were defatted in petroleum ether (VWR International, West Chester, PA) and extracted in acetone-water-acetic acid (90:9.5:0.5) at 60°C for 8 h using a Soxhlet apparatus (7) . The crude extracts were concentrated under vacuum, resuspended in methanol, and filter sterilized (0.2 m; VWR). All extracts were stored at Ϫ20°C in the dark and used within 1 week. The total phenolic content of each extract was determined by the Folin-Singleton colorimetric method (21) and expressed as mg gallic acid equivalents (GAE)/g extract dry weight (dw). Major phenolics were measured by high-performance liquid chromatography as previously described (20) and reported as mg/g extract dw.
The anti-H. pylori activities of grape extracts (range, 256 to 2,048 g/ml) and the pure compounds resveratrol, ellagic acid, and myricetin (range, 6.25 to 50 g/ml) (Sigma) were evaluated by the agar dilution method in duplicate (14a). Each bacterial suspension was spot inoculated (ca. 1 ϫ 10 5 CFU/ spot) onto brain heart infusion-HS plates containing each antimicrobial, and the MIC was determined following incubation at 37°C for 3 days under microaerophilic conditions. AGS cells (ATCC CRL-1739; American Type Culture Collection, Manassas, VA) were grown in Ham's F-12K medium supplemented with 10% fetal bovine serum (HyClone Laboratories, South Logan, UT) and incubated at 37°C in a 5% CO 2 incubator with 100% humidity to 90% confluence. Cells were washed with phosphate-buffered saline (PBS; pH 7.4) and de-tached using 0.25% trypsin-EDTA (Sigma). Cell concentrations were determined using trypan blue and a hemocytometer.
For cell viability assays, overnight cultures of H. pylori strains 26695, P1pDH80, and SS1 at final concentrations of 5 ϫ 10 5 CFU/ml were treated with grape extract or pure compounds for different times (see Table 2 ). Following treatment, H. pylori was pelleted by centrifugation (3,500 ϫ g for 10 min), washed twice with sterile PBS, and resuspended in fresh cell culture medium. AGS cells were grown as described previously, distributed into 96 cell culture wells (Corning Costar Corp., Cambridge, MA), and incubated overnight to allow for adherence. Extract-treated H. pylori cultures (26695, P1pDH80, and SS1) were distributed to each well at a bacterium-to-AGS-cell ratio of 100:1 (based on the control, i.e., AGS cells infected with H. pylori without treatment). This was necessary since AGS cell growth was sensitive to both extracts and constituent compounds in preliminary experiments (data not shown). Following overnight incubation, the culture medium was replaced with RPMI 1640 (HyClone Laboratories) after washing with sterile PBS to remove nonadherent H. pylori cells. AGS cell proliferation was then determined by adding 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) solution (CellTiter 96 AQ ueous onesolution proliferation assay; Promega, Madison, WI) following the manufacturer's directions. Absorbances were read at 490 nm using a BioTek -Quant microplate reader (Bio-Tek Instruments, Inc., Winooski, VT) and standardized against the AGS cell control.
The effects of muscadine grape extracts on H. pylori attachment to AGS cells were also determined by confocal laser scanning microscopy. Overnight cultures of GFP-labeled H. pylori P1pDH80 were treated with different concentrations of muscadine grape extracts for 1, 2, 4, 6, 12, and 24 h under microaerophilic conditions. Following treatment, H. pylori cells were washed in sterile PBS and incubated for 1 h with overnight cultures of AGS cells attached to eight-well Labtek chamber slides (Fisher Scientific, Norcross, GA) at low density. Following the removal of nonadherent cells, the attachment of GFP-labeled H. pylori to host cells was examined using a Zeiss LSM-510 laser scanning confocal microscope (Carl Zeiss, Inc., Germany).
During storage, total phenolic levels in grape extracts declined significantly, with up to 46% of the phenolic content lost during 3-month storage at 4°C and Ϫ15°C (data not shown). However, phenolic levels for grape extracts stored at Ϫ80°C (with or without N 2 ) did not significantly decrease (P Ͼ 0.05) within the first month. Due to the rapid loss of total phenolic compounds in grape extracts, all the experiments were carefully implemented as to maximize the retention of these bioactive compounds.
The MIC results indicate that the grape extracts and pure compounds have significant but differing effects against H. pylori growth (Table 1) . Muscadine grape skin extract was most effective (MIC range, 256 to 512 g/ml), followed by muscadine seed (MIC range, 256 to 1,024 g/ml) and synergy extracts (skin and seed) (MIC range, 512 to 1,024 g/ml). Resveratrol and ellagic acid also inhibited H. pylori (MIC range, 6.25 to 50 g/ml); however, myricetin had no effect and was not tested further (Table 1 ). Figure 1 shows that there were substantial reductions in AGS cell viabilities following 24-h H. pylori infection with all three tested strains as determined by MTS assay. However, following treatment of the cells with grape extracts, average AGS cell growth was significantly higher than the controls (Table 2 ) and directly proportional to both extract concentration (P Ͻ 0.05) and treatment time (P Ͻ 0.05). Muscadine grape skin extract had the highest anti-H. pylori activity following 24 h treatment (AGS cell growth range, 97.8 to 99.4% at 4,096 g/ml), followed by muscadine grape synergy and seed extract ( Table 2) . Treatment of H. pylori 26695 and SS1 with resveratrol (6.25 to 50 g/ml) and ellagic acid (6.25 to 50 g/ml) was also effective (data not shown); however, no significant difference (P Ͼ 0.05) was found between AGS cell growth following treatment of these two H. pylori strains with these compounds. Because bacteria were treated in the absence of AGS cells, H. pylori populations used for MTS assays varied. Therefore, AGS cells were exposed to different concentrations of H. pylori 26695 without muscadine grape extract treatment for 24 h and measured by MTS assay. AGS cell growth with extract-treated H. pylori (12 h) was then compared to a standard curve. Figure  2 shows that AGS cell growth was higher for extract-treated H. pylori 26695 at the same cell populations as controls, indicating that additional factors, besides reduced bacterial numbers, may affect H. pylori following treatment.
Treatment with muscadine grape skin extract resulted in a significant decrease in H. pylori attachment to AGS cells compared to that of controls (Fig. 3) . All extracts (range, 1,024 to 4,096 g/ml) reduced H. pylori attachment with effects observed at the lowest concentration (data not shown). The majority of the GFP-labeled H. pylori cells were coccoidal in form and appeared to clump at higher extract concentrations and longer treatment times, especially at 12 and 24 h, indicating a decline in attachment efficiency (Fig. 3) .
Phenolic compounds in grape products play important roles for antioxidant, anti-inflammatory, and antimicrobial effects (13, 18, 20) . In this study, muscadine grape seed extract contained the highest total phenolic content (645.5 mg GAE/g dw), followed by muscadine synergy and skin extracts (381.9 and 135.0 mg GAE/g dw, respectively). Total phenolic concentrations in muscadine seed extracts were approximately five times higher than its skin counterpart, a finding consistent with that previously reported by Pastrana-Bonilla et al. (18) . Highperformance liquid chromatography results were also in agreement with the previous study for the major phenolics ellagic acid, myricetin, quercetin, and resveratrol with respective average concentrations of 77.3, 22.5, 3.4, and 1.4 mg/g extract dw.
In this study, muscadine grape skin extract was most effective against H. pylori in all tests performed. Although muscadine grape seed contained significantly higher total phenolic levels than other extracts, its efficacy against H. pylori was lower than or similar to that of muscadine skin and synergy extracts (Tables 1 and 2 ), suggesting that higher phenolic levels do not necessarily correlate with increased anti-H. pylori activity but rather the type and concentrations of compounds present in these extracts. Resveratrol, the least-abundant major phenolic in muscadine grape skin, has been shown to inhibit cagApositive H. pylori strains (6) . Ellagic acid, the most-abundant phenolic, has also been reported to possess anti-H. pylori activity (15) . In addition, this compound has been found to inhibit cancer, alter bacterial protein conformations, and affect ion pump function (11, 22) ; however, it is not known if a similar mode of action against H. pylori exists. Because these phenolics are partially hydrophobic, this may allow them to interact with the bacterial cell wall and lipopolysaccharide interfaces more effectively by decreasing membrane stability (25) . Therefore, further research on individual compounds and their interactions in the fruit itself is necessary to elucidate the possible 0  2  6  1 2  2 4   26695  P1  SS1  26695  P1  SS1  26695  P1  SS1  26695  P1  SS1  26695  P1 (1, 9, 17) . Confocal microscopy revealed fewer bacterial cells present on host cell surfaces following treatment with grape extracts (Fig. 3) , in agreement with AGS cell proliferation assays. Two possible explanations are that these compounds may interfere with H. pylori's ability to increase the expression of AGS cell adhesion molecules (10) or inhibit sialic acid-specific adhesions to epithelial cells (1) .
Following treatment with muscadine grape extracts or compounds, AGS cell proliferation was similar to that of the controls without H. pylori ( Table 2 ), suggesting that extracts either reduce or inhibit H. pylori from binding to and/or damaging AGS cells. Figure 2 reveals that approximately 2 log CFU H. pylori/ml in extract-treated populations lost the ability to damage host cells, suggesting that some unknown factor(s), in addition to lower H. pylori numbers, may be responsible for higher cell proliferation levels. The loss of attachment potential for H. pylori following grape extract treatment could be due to many levels of damage and injury to the microorganism, including the inhibition of basic energy production and/or virulence factors. Because H. pylori VacA toxin is known to cause gastric injury via damage to host stomach cells, the increased AGS cell proliferation may be attributed to the inhibition of vacA-induced ion channel formation, urea conduction, and cell vacuolization (24) . The polyphenol compounds may form aggregates with the toxin, in turn preventing its receptor binding and internalization into the host cell (27) . A recent finding by Ruggiero et al. (19) found that red wine was able to prevent H. pylori-induced gastric epithelium damage in mice, suggesting that VacA inhibition may be involved. However, further studies are needed to determine the specific effect(s) (e.g., loss of attachment mechanisms, virulence factors, host membrane integrity, etc.) these extracts have on the organism's overall pathogenesis.
In this study, grape extracts and their compounds were effective at inhibiting H. pylori in vitro, with highest efficacy by muscadine grape skin extract. Although anti-H. pylori activities by individual compounds were reported, it is believed that a synergistic mode of action is more likely responsible for the extract's antimicrobial activity (26) . However, these complex interactions among compounds found in these extracts have yet to be determined. Our results suggest that anti-H. pylori activity does not necessarily correlate with higher phenolic content as previously thought. This study supports the need for further research to fully evaluate the in vivo potential of grape extracts and constituent compounds for use in the dietary management of H. pylori infection. 
